Behandling af hydatidose med albendazol
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Behandling af hydatidose med albendazol. / Magnussen, P; Gelletlie, R; Bygbjerg, Ib Christian.
I: Ugeskrift for Laeger, Bind 151, Nr. 43, 23.10.1989, s. 2791-4.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Behandling af hydatidose med albendazol
AU - Magnussen, P
AU - Gelletlie, R
AU - Bygbjerg, Ib Christian
PY - 1989/10/23
Y1 - 1989/10/23
N2 - Eight patients with hydatidosis treated with albendazol in daily doses of 10 mg/kg daily in courses of 28 days (4-6 courses) were analysed. The patients came from Morocco, Spain, Turkey and Yugoslavia. Seven patients had a cyst (or cysts) in the liver and one had also cysts in the kidneys. One patient had cysts in the muscles of the extremities. As assessed by ultrasonic scanning, computed tomography of the cysts, general condition, serology and the presence of hydatid antigen in the serum, treatment was effective in six patients. One patient developed an allergic reaction to albendazol. All of the patients had varying degrees of liver involvement which were reversible. Neutropenia did not occur. Various parameters for assessing the therapeutic effect are mentioned. Albendazol appears to be effective in the treatment of non-operable hydatid disease and to prevent recurrence after surgery.
AB - Eight patients with hydatidosis treated with albendazol in daily doses of 10 mg/kg daily in courses of 28 days (4-6 courses) were analysed. The patients came from Morocco, Spain, Turkey and Yugoslavia. Seven patients had a cyst (or cysts) in the liver and one had also cysts in the kidneys. One patient had cysts in the muscles of the extremities. As assessed by ultrasonic scanning, computed tomography of the cysts, general condition, serology and the presence of hydatid antigen in the serum, treatment was effective in six patients. One patient developed an allergic reaction to albendazol. All of the patients had varying degrees of liver involvement which were reversible. Neutropenia did not occur. Various parameters for assessing the therapeutic effect are mentioned. Albendazol appears to be effective in the treatment of non-operable hydatid disease and to prevent recurrence after surgery.
KW - Adolescent
KW - Adult
KW - Aged
KW - Albendazole
KW - Anthelmintics
KW - Denmark
KW - Echinococcosis
KW - Echinococcosis, Hepatic
KW - Emigration and Immigration
KW - Female
KW - Humans
KW - Male
M3 - Tidsskriftartikel
C2 - 2588356
VL - 151
SP - 2791
EP - 2794
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 43
ER -
ID: 33891158